Share Price and Basic Stock Data
Last Updated: October 18, 2025, 4:34 pm
PEG Ratio | 3.05 |
---|
Analyst Insight & Comprehensive Analysis
AXISCADES Technologies Ltd, operating in the IT Enabled Services sector, currently trades at ₹1,684 with a Market Cap of ₹7,156 Cr. The company exhibits a high P/E ratio of 87.5, which is notably above the sector average of around 30 in India. Despite this, AXISCADES boasts a respectable ROE of 12.7% and ROCE of 13.8%, indicating efficient capital utilization. With a healthy operating profit margin of 14% and a strong net profit of ₹75 Cr, the company demonstrates operational effectiveness. Moreover, the company’s conservative capital structure is evident from its borrowing of ₹256 Cr against reserves of ₹628 Cr, ensuring a solid Interest Coverage Ratio of 2.54x.However, AXISCADES faces risks due to its relatively high P/E ratio, which may imply overvaluation compared to industry peers. Additionally, the company’s Current Capital Cycle of 111 days raises concerns about working capital management efficiency. Looking ahead, AXISCADES could enhance its performance by improving working capital efficiency to reduce the CCC, thereby strengthening cash flows and profitability. Moreover, diversifying its shareholder base beyond the current high promoter holding of 58.20% could enhance market confidence and liquidity, potentially unlocking value for investors. In a competitive market, maintaining a balance between growth and profitability will be crucial for AXISCADES to navigate challenges and capitalize on opportunities effectively.Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of AXISCADES Technologies Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
N2N Technologies Ltd | 8.60 Cr. | 26.6 | 30.5/14.2 | 6.06 | 21.4 | 0.00 % | 19.6 % | 22.4 % | 10.0 |
eMudhra Ltd | 5,259 Cr. | 635 | 1,024/625 | 57.4 | 90.0 | 0.20 % | 15.3 % | 12.1 % | 5.00 |
BNR Udyog Ltd | 14.7 Cr. | 48.9 | 90.0/44.5 | 32.3 | 0.00 % | 10.0 % | 5.52 % | 10.0 | |
BLS E-Services Ltd | 1,597 Cr. | 176 | 249/131 | 28.9 | 53.1 | 0.57 % | 15.8 % | 11.0 % | 10.0 |
BGIL Films & Technologies Ltd | 19.8 Cr. | 17.5 | 18.4/4.80 | 16.9 | 0.00 % | 0.34 % | 0.88 % | 10.0 | |
Industry Average | 7,791.13 Cr | 649.55 | 33.04 | 182.10 | 0.42% | 20.05% | 20.85% | 7.41 |
Quarterly Result
Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 184 | 196 | 216 | 226 | 215 | 252 | 232 | 256 | 224 | 265 | 275 | 268 | 244 |
Expenses | 161 | 156 | 184 | 179 | 181 | 216 | 202 | 223 | 192 | 231 | 234 | 231 | 210 |
Operating Profit | 24 | 39 | 32 | 47 | 34 | 37 | 30 | 32 | 31 | 33 | 40 | 37 | 34 |
OPM % | 13% | 20% | 15% | 21% | 16% | 15% | 13% | 13% | 14% | 13% | 15% | 14% | 14% |
Other Income | -42 | 4 | -22 | 1 | 2 | 1 | 2 | 5 | 10 | 4 | 1 | 2 | 11 |
Interest | 2 | 8 | 12 | 14 | 20 | 12 | 12 | 13 | 8 | 9 | 7 | 8 | 7 |
Depreciation | 6 | 7 | 6 | 7 | 7 | 9 | 8 | 10 | 9 | 10 | 11 | 10 | 9 |
Profit before tax | -26 | 28 | -8 | 27 | 8 | 18 | 11 | 16 | 24 | 19 | 23 | 21 | 28 |
Tax % | 20% | 25% | 32% | 41% | 33% | 36% | 32% | 44% | 31% | 35% | 36% | -47% | 25% |
Net Profit | -32 | 21 | -10 | 16 | 6 | 11 | 8 | 9 | 17 | 12 | 15 | 32 | 21 |
EPS in Rs | -8.37 | 5.52 | -2.71 | 4.16 | 1.47 | 2.88 | 1.93 | 2.08 | 4.07 | 2.91 | 3.49 | 7.24 | 4.88 |
Last Updated: August 20, 2025, 1:15 pm
Below is a detailed analysis of the quarterly data for AXISCADES Technologies Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 244.00 Cr.. The value appears to be declining and may need further review. It has decreased from 268.00 Cr. (Mar 2025) to 244.00 Cr., marking a decrease of 24.00 Cr..
- For Expenses, as of Jun 2025, the value is 210.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 231.00 Cr. (Mar 2025) to 210.00 Cr., marking a decrease of 21.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 34.00 Cr.. The value appears to be declining and may need further review. It has decreased from 37.00 Cr. (Mar 2025) to 34.00 Cr., marking a decrease of 3.00 Cr..
- For OPM %, as of Jun 2025, the value is 14.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 14.00%.
- For Other Income, as of Jun 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 9.00 Cr..
- For Interest, as of Jun 2025, the value is 7.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.00 Cr. (Mar 2025) to 7.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 9.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Mar 2025) to 28.00 Cr., marking an increase of 7.00 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from -47.00% (Mar 2025) to 25.00%, marking an increase of 72.00%.
- For Net Profit, as of Jun 2025, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 32.00 Cr. (Mar 2025) to 21.00 Cr., marking a decrease of 11.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 4.88. The value appears to be declining and may need further review. It has decreased from 7.24 (Mar 2025) to 4.88, marking a decrease of 2.36.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:39 am
Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 307 | 318 | 375 | 487 | 519 | 608 | 673 | 524 | 610 | 822 | 955 | 1,031 | 1,051 |
Expenses | 278 | 276 | 322 | 448 | 501 | 595 | 580 | 459 | 539 | 675 | 826 | 886 | 906 |
Operating Profit | 29 | 42 | 54 | 39 | 18 | 13 | 93 | 65 | 72 | 146 | 129 | 144 | 145 |
OPM % | 9% | 13% | 14% | 8% | 4% | 2% | 14% | 12% | 12% | 18% | 14% | 14% | 14% |
Other Income | 3 | -1 | 3 | 15 | 12 | 24 | 8 | -26 | 7 | -62 | 16 | 16 | 17 |
Interest | 4 | 3 | 2 | 13 | 14 | 25 | 30 | 24 | 17 | 37 | 58 | 34 | 32 |
Depreciation | 8 | 9 | 10 | 12 | 19 | 20 | 33 | 26 | 25 | 27 | 34 | 40 | 40 |
Profit before tax | 20 | 29 | 45 | 29 | -3 | -8 | 38 | -10 | 37 | 21 | 53 | 88 | 91 |
Tax % | 18% | 31% | 35% | 50% | 181% | -9% | 21% | 104% | 38% | 123% | 37% | 14% | |
Net Profit | 16 | 20 | 29 | 15 | -8 | -8 | 30 | -21 | 23 | -5 | 33 | 75 | 79 |
EPS in Rs | 8.01 | 7.14 | 10.51 | 3.74 | -2.18 | -2.15 | 7.88 | -5.74 | 5.86 | -1.37 | 7.82 | 17.63 | 18.52 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 25.00% | 45.00% | -48.28% | -153.33% | 0.00% | 475.00% | -170.00% | 209.52% | -121.74% | 760.00% | 127.27% |
Change in YoY Net Profit Growth (%) | 0.00% | 20.00% | -93.28% | -105.06% | 153.33% | 475.00% | -645.00% | 379.52% | -331.26% | 881.74% | -632.73% |
AXISCADES Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 9% |
3 Years: | 19% |
TTM: | 9% |
Compounded Profit Growth | |
---|---|
10 Years: | 14% |
5 Years: | 21% |
3 Years: | 49% |
TTM: | 85% |
Stock Price CAGR | |
---|---|
10 Years: | 18% |
5 Years: | 86% |
3 Years: | 109% |
1 Year: | 141% |
Return on Equity | |
---|---|
10 Years: | 5% |
5 Years: | 6% |
3 Years: | 6% |
Last Year: | 13% |
Last Updated: September 5, 2025, 12:10 am
Balance Sheet
Last Updated: October 10, 2025, 1:42 pm
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10 | 14 | 14 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 21 | 21 |
Reserves | 91 | 112 | 144 | 283 | 273 | 266 | 296 | 280 | 312 | 319 | 564 | 628 |
Borrowings | 33 | 26 | 27 | 81 | 138 | 152 | 172 | 104 | 72 | 346 | 319 | 258 |
Other Liabilities | 41 | 36 | 58 | 77 | 328 | 337 | 375 | 340 | 392 | 220 | 231 | 216 |
Total Liabilities | 175 | 188 | 243 | 459 | 758 | 774 | 862 | 742 | 796 | 904 | 1,135 | 1,123 |
Fixed Assets | 34 | 49 | 48 | 159 | 344 | 339 | 355 | 288 | 286 | 312 | 414 | 398 |
CWIP | 14 | 0 | 1 | 6 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 8 |
Investments | 1 | 0 | 0 | 0 | 6 | 30 | 34 | 50 | 19 | 33 | 37 | 60 |
Other Assets | 126 | 139 | 195 | 294 | 407 | 404 | 473 | 404 | 491 | 559 | 685 | 658 |
Total Assets | 175 | 188 | 243 | 459 | 758 | 774 | 862 | 742 | 796 | 904 | 1,135 | 1,123 |
Below is a detailed analysis of the balance sheet data for AXISCADES Technologies Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 21.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 21.00 Cr..
- For Reserves, as of Mar 2025, the value is 628.00 Cr.. The value appears strong and on an upward trend. It has increased from 564.00 Cr. (Mar 2024) to 628.00 Cr., marking an increase of 64.00 Cr..
- For Borrowings, as of Mar 2025, the value is 258.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 319.00 Cr. (Mar 2024) to 258.00 Cr., marking a decrease of 61.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 216.00 Cr.. The value appears to be improving (decreasing). It has decreased from 231.00 Cr. (Mar 2024) to 216.00 Cr., marking a decrease of 15.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,123.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,135.00 Cr. (Mar 2024) to 1,123.00 Cr., marking a decrease of 12.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 398.00 Cr.. The value appears to be declining and may need further review. It has decreased from 414.00 Cr. (Mar 2024) to 398.00 Cr., marking a decrease of 16.00 Cr..
- For CWIP, as of Mar 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 8.00 Cr., marking an increase of 8.00 Cr..
- For Investments, as of Mar 2025, the value is 60.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Mar 2024) to 60.00 Cr., marking an increase of 23.00 Cr..
- For Other Assets, as of Mar 2025, the value is 658.00 Cr.. The value appears to be declining and may need further review. It has decreased from 685.00 Cr. (Mar 2024) to 658.00 Cr., marking a decrease of 27.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,123.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,135.00 Cr. (Mar 2024) to 1,123.00 Cr., marking a decrease of 12.00 Cr..
Notably, the Reserves (628.00 Cr.) exceed the Borrowings (258.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -4.00 | 16.00 | 27.00 | -42.00 | -120.00 | -139.00 | -79.00 | -39.00 | 0.00 | -200.00 | -190.00 | -114.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 86 | 70 | 82 | 63 | 117 | 92 | 90 | 89 | 87 | 80 | 89 | 107 |
Inventory Days | 11 | 200 | 88 | 84 | 86 | 165 | 134 | 136 | 104 | |||
Days Payable | 150 | 333 | 137 | 177 | 188 | 218 | 153 | 125 | 100 | |||
Cash Conversion Cycle | 86 | 70 | 82 | -76 | -16 | 44 | -3 | -12 | 34 | 61 | 100 | 111 |
Working Capital Days | 39 | 47 | 51 | 32 | 1 | -39 | -55 | -71 | -73 | 23 | 49 | 75 |
ROCE % | 18% | 24% | 28% | 14% | 4% | 1% | 15% | 12% | 14% | 23% | 14% | 14% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
ICICI Prudential Technology Fund | 1,359,517 | 0.89 | 108.55 | 1,359,517 | 2025-04-22 17:25:41 | 0% |
Key Financial Ratios
Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
---|---|---|---|---|---|
FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Basic EPS (Rs.) | 17.76 | 8.40 | -1.37 | 5.86 | -5.74 |
Diluted EPS (Rs.) | 17.22 | 7.74 | -1.37 | 5.76 | -5.74 |
Cash EPS (Rs.) | 27.02 | 16.01 | 5.69 | 12.70 | 1.15 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 152.62 | 140.97 | 89.95 | 88.71 | 80.31 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 152.62 | 140.97 | 89.95 | 88.71 | 80.31 |
Revenue From Operations / Share (Rs.) | 242.36 | 227.52 | 214.92 | 160.84 | 138.62 |
PBDIT / Share (Rs.) | 38.40 | 34.11 | 39.63 | 21.01 | 20.76 |
PBIT / Share (Rs.) | 29.09 | 26.06 | 32.70 | 14.41 | 13.89 |
PBT / Share (Rs.) | 20.58 | 12.63 | 5.51 | 9.81 | -2.87 |
Net Profit / Share (Rs.) | 17.71 | 7.96 | -1.24 | 6.10 | -5.73 |
NP After MI And SOA / Share (Rs.) | 17.62 | 7.82 | -1.37 | 5.86 | -5.73 |
PBDIT Margin (%) | 15.84 | 14.99 | 18.44 | 13.06 | 14.97 |
PBIT Margin (%) | 12.00 | 11.45 | 15.21 | 8.95 | 10.01 |
PBT Margin (%) | 8.49 | 5.55 | 2.56 | 6.09 | -2.06 |
Net Profit Margin (%) | 7.30 | 3.49 | -0.57 | 3.79 | -4.13 |
NP After MI And SOA Margin (%) | 7.27 | 3.43 | -0.63 | 3.64 | -4.13 |
Return on Networth / Equity (%) | 11.54 | 5.60 | -1.54 | 6.71 | -7.25 |
Return on Capital Employeed (%) | 14.78 | 13.76 | 22.84 | 15.24 | 13.04 |
Return On Assets (%) | 6.64 | 2.88 | -0.57 | 2.79 | -2.91 |
Long Term Debt / Equity (X) | 0.16 | 0.18 | 0.50 | 0.00 | 0.06 |
Total Debt / Equity (X) | 0.29 | 0.40 | 0.92 | 0.14 | 0.17 |
Asset Turnover Ratio (%) | 0.90 | 0.93 | 0.96 | 0.30 | 0.19 |
Current Ratio (X) | 2.22 | 1.92 | 1.51 | 0.99 | 1.07 |
Quick Ratio (X) | 2.01 | 1.72 | 1.32 | 0.87 | 1.00 |
Inventory Turnover Ratio (X) | 15.83 | 2.40 | 3.05 | 0.00 | 0.00 |
Interest Coverage Ratio (X) | 5.06 | 2.54 | 4.22 | 5.06 | 3.49 |
Interest Coverage Ratio (Post Tax) (X) | 3.45 | 1.59 | 2.76 | 2.58 | 1.85 |
Enterprise Value (Cr.) | 3885.16 | 2412.17 | 1244.16 | 431.26 | 122.34 |
EV / Net Operating Revenue (X) | 3.77 | 2.53 | 1.51 | 0.70 | 0.23 |
EV / EBITDA (X) | 23.79 | 16.85 | 8.21 | 5.41 | 1.56 |
MarketCap / Net Operating Revenue (X) | 3.67 | 2.43 | 1.25 | 0.79 | 0.28 |
Price / BV (X) | 5.82 | 3.96 | 3.03 | 1.46 | 0.50 |
Price / Net Operating Revenue (X) | 3.67 | 2.43 | 1.25 | 0.79 | 0.28 |
EarningsYield | 0.01 | 0.01 | -0.01 | 0.04 | -0.14 |
After reviewing the key financial ratios for AXISCADES Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 17.76. This value is within the healthy range. It has increased from 8.40 (Mar 24) to 17.76, marking an increase of 9.36.
- For Diluted EPS (Rs.), as of Mar 25, the value is 17.22. This value is within the healthy range. It has increased from 7.74 (Mar 24) to 17.22, marking an increase of 9.48.
- For Cash EPS (Rs.), as of Mar 25, the value is 27.02. This value is within the healthy range. It has increased from 16.01 (Mar 24) to 27.02, marking an increase of 11.01.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 152.62. It has increased from 140.97 (Mar 24) to 152.62, marking an increase of 11.65.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 152.62. It has increased from 140.97 (Mar 24) to 152.62, marking an increase of 11.65.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 242.36. It has increased from 227.52 (Mar 24) to 242.36, marking an increase of 14.84.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 38.40. This value is within the healthy range. It has increased from 34.11 (Mar 24) to 38.40, marking an increase of 4.29.
- For PBIT / Share (Rs.), as of Mar 25, the value is 29.09. This value is within the healthy range. It has increased from 26.06 (Mar 24) to 29.09, marking an increase of 3.03.
- For PBT / Share (Rs.), as of Mar 25, the value is 20.58. This value is within the healthy range. It has increased from 12.63 (Mar 24) to 20.58, marking an increase of 7.95.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 17.71. This value is within the healthy range. It has increased from 7.96 (Mar 24) to 17.71, marking an increase of 9.75.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 17.62. This value is within the healthy range. It has increased from 7.82 (Mar 24) to 17.62, marking an increase of 9.80.
- For PBDIT Margin (%), as of Mar 25, the value is 15.84. This value is within the healthy range. It has increased from 14.99 (Mar 24) to 15.84, marking an increase of 0.85.
- For PBIT Margin (%), as of Mar 25, the value is 12.00. This value is within the healthy range. It has increased from 11.45 (Mar 24) to 12.00, marking an increase of 0.55.
- For PBT Margin (%), as of Mar 25, the value is 8.49. This value is below the healthy minimum of 10. It has increased from 5.55 (Mar 24) to 8.49, marking an increase of 2.94.
- For Net Profit Margin (%), as of Mar 25, the value is 7.30. This value is within the healthy range. It has increased from 3.49 (Mar 24) to 7.30, marking an increase of 3.81.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.27. This value is below the healthy minimum of 8. It has increased from 3.43 (Mar 24) to 7.27, marking an increase of 3.84.
- For Return on Networth / Equity (%), as of Mar 25, the value is 11.54. This value is below the healthy minimum of 15. It has increased from 5.60 (Mar 24) to 11.54, marking an increase of 5.94.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.78. This value is within the healthy range. It has increased from 13.76 (Mar 24) to 14.78, marking an increase of 1.02.
- For Return On Assets (%), as of Mar 25, the value is 6.64. This value is within the healthy range. It has increased from 2.88 (Mar 24) to 6.64, marking an increase of 3.76.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.16. This value is below the healthy minimum of 0.2. It has decreased from 0.18 (Mar 24) to 0.16, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.29. This value is within the healthy range. It has decreased from 0.40 (Mar 24) to 0.29, marking a decrease of 0.11.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.90. It has decreased from 0.93 (Mar 24) to 0.90, marking a decrease of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 2.22. This value is within the healthy range. It has increased from 1.92 (Mar 24) to 2.22, marking an increase of 0.30.
- For Quick Ratio (X), as of Mar 25, the value is 2.01. This value exceeds the healthy maximum of 2. It has increased from 1.72 (Mar 24) to 2.01, marking an increase of 0.29.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 15.83. This value exceeds the healthy maximum of 8. It has increased from 2.40 (Mar 24) to 15.83, marking an increase of 13.43.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 5.06. This value is within the healthy range. It has increased from 2.54 (Mar 24) to 5.06, marking an increase of 2.52.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.45. This value is within the healthy range. It has increased from 1.59 (Mar 24) to 3.45, marking an increase of 1.86.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,885.16. It has increased from 2,412.17 (Mar 24) to 3,885.16, marking an increase of 1,472.99.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.77. This value exceeds the healthy maximum of 3. It has increased from 2.53 (Mar 24) to 3.77, marking an increase of 1.24.
- For EV / EBITDA (X), as of Mar 25, the value is 23.79. This value exceeds the healthy maximum of 15. It has increased from 16.85 (Mar 24) to 23.79, marking an increase of 6.94.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.67. This value exceeds the healthy maximum of 3. It has increased from 2.43 (Mar 24) to 3.67, marking an increase of 1.24.
- For Price / BV (X), as of Mar 25, the value is 5.82. This value exceeds the healthy maximum of 3. It has increased from 3.96 (Mar 24) to 5.82, marking an increase of 1.86.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.67. This value exceeds the healthy maximum of 3. It has increased from 2.43 (Mar 24) to 3.67, marking an increase of 1.24.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in AXISCADES Technologies Ltd:
- Net Profit Margin: 7.3%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14.78% (Industry Average ROCE: 20.05%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 11.54% (Industry Average ROE: 20.85%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.45
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.01
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 78.9 (Industry average Stock P/E: 19.52)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.29
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.3%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Aerospace & Defense | Block C, Second Floor, Bengaluru Karnataka 560024 | info@axiscades.in http://www.axiscades.com |
Management | |
---|---|
Name | Position Held |
Dr. Sampath Ravinarayanan | Chairman & Managing Director |
Mr. Venkatraman Venkitachalam | Non Executive Director |
Lt. Gen. Codanda Poovaiah Cariappa | Independent Director |
Mr. Tanmoy Chakrabarty | Independent Director |
Mrs. Mariam Mathew | Independent Woman Director |
FAQ
What is the intrinsic value of AXISCADES Technologies Ltd?
AXISCADES Technologies Ltd's intrinsic value (as of 18 October 2025) is 1251.01 which is 17.53% lower the current market price of 1,517.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 6,448 Cr. market cap, FY2025-2026 high/low of 1,779/421, reserves of ₹628 Cr, and liabilities of 1,123 Cr.
What is the Market Cap of AXISCADES Technologies Ltd?
The Market Cap of AXISCADES Technologies Ltd is 6,448 Cr..
What is the current Stock Price of AXISCADES Technologies Ltd as on 18 October 2025?
The current stock price of AXISCADES Technologies Ltd as on 18 October 2025 is 1,517.
What is the High / Low of AXISCADES Technologies Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of AXISCADES Technologies Ltd stocks is 1,779/421.
What is the Stock P/E of AXISCADES Technologies Ltd?
The Stock P/E of AXISCADES Technologies Ltd is 78.9.
What is the Book Value of AXISCADES Technologies Ltd?
The Book Value of AXISCADES Technologies Ltd is 153.
What is the Dividend Yield of AXISCADES Technologies Ltd?
The Dividend Yield of AXISCADES Technologies Ltd is 0.00 %.
What is the ROCE of AXISCADES Technologies Ltd?
The ROCE of AXISCADES Technologies Ltd is 13.8 %.
What is the ROE of AXISCADES Technologies Ltd?
The ROE of AXISCADES Technologies Ltd is 12.7 %.
What is the Face Value of AXISCADES Technologies Ltd?
The Face Value of AXISCADES Technologies Ltd is 5.00.